ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI

August 27, 2010

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Centers Core Support To Be Trimmed By Dropping Funds for Scientists Salaries, Shared Resources

September 23, 1977

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983

In Brief: Balch To Head City of Hope; Rowinsky Moves To San Antonio; Klausner’s Deputy Joins NCI

August 9, 1996

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007